Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: A 11C-flumazenil PET study

Journal of Nuclear Medicine

Volumn 46, Issue 12, 2005, Pages 1973-1979

  Yamauchi, Hiroshi ^a   Kudoh, Takashi ^a   Kishibe, Yoshihiko ^a   Iwasaki, Jinei ^a   Kagawa, Shinya ^a  

^a Shiga Medical Center Research Institute   (Japan)

Author keywords

Benzodiazepine receptors; Borderzone infarct; Carotid artery disease; Emission tomography, computed

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL C 11; UNCLASSIFIED DRUG; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; FLUMAZENIL; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BORDERZONE INFARCTION; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN CORTEX; CAROTID ARTERY DISEASE; CEREBELLUM; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEMODYNAMICS; METABOLISM; METHODOLOGY; NERVE CELL; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SCINTISCANNING; STATISTICAL MODEL; TIME; TRANSIENT ISCHEMIC ATTACK;

ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; CEREBELLUM; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; FLUMAZENIL; GABA MODULATORS; HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MODELS, STATISTICAL; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 33644875404     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 1996;27:761-765.
2. Lassen NA, Olsen TS, Højgaard K, Skriver E. Incomplete infarction: a CT-negative irreversible ischemic brain lesion [abstract]. J Cereb Blood Flow Metab. 1983;3(suppl 1):S602-S603.
3. Sette G, Baron JC, Young AR, et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 1993;24:2046-2057.
4. Hatazawa J, Satoh T, Shimosegawa E, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. J Nucl Med. 1995;36:2154-2161.
5. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantified with iomazenil. Stroke. 1997;28:1124-1132.
6. Heiss WD, Grond M, Thiel A, et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke. 1998;29:454-461.
7. Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease: a comparison with PET study. Stroke. 1997;28:1776-1782.
8. Sasaki M, Ichiya Y, Kuwabara Y, Yoshida T, Fukumura T, Masuda K. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism. J Nucl Med. 1997;38:1693-1698.
9. Moriwaki H, Matsumoto M, Hashikawa K, et al. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med. 1998;39:1348-1353.
10. Yamauchi H, Fukuyama H, Dong Y, et al. Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases. J Neurol Neurosurg Psychiatry. 2000;68:317-322.
11. Kuroda S, Shiga T, Ishikawa T, et al. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med. 2004;45:943-949.
12. Bogousslavsky J, Regli FA. Unilateral watershed cerebral infarcts. Neurology. 1986;36:373-377.
13. Momjian-Mayor I, Baron JC. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke. 2005;36:567-577.
14. North Amercian Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
15. 15O gas and water. J Cereb Blood Flow Metab. 2001;21:793-803.
16. 11C-flumazenil in clinical positron emission tomography studies. J Comput Assist Tomogr. 2004;28:428-435.
17. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr. 1980;4:727-736.
18. Lammertsma AA, Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain. 1. Description of the method. J Cereb Blood Flow Metab. 1983;3:416-424.
19. Kretschmann HJ, Weinrich W. Neuroanatomy and Cranial Computed Tomography. New York, NY: Thieme-Stratton Inc; 1986:70-74.
20. Zülch KJ, Hossmann V. Patterns of cerebral infarctions. In: Vinken PJ, Bruyn GW, Klawans HL, Toole JF, eds. Handbook of Clinical Neurology: Vascular Disease. Vol. 53. Amsterdam, The Netherlands: Elsevier Science; 1988:175-198.
21. Bladin PF, Berkovic SF. Striatocapsular infarction: large infarcts in the lenticulostriate arterial territory. Neurology. 1984;34:1423-1430.
22. Yamauchi H, Fukuyama H, Kimura J, Konishi J, Kameyama M. Hemodynamics in internal carotid artery occlusion examined by positron emission tomography. Stroke. 1990;21:1400-1406.
23. Yamauchi H, Fukuyama H, Harada K, et al. White matter hyperintensities may correspond to areas of increased blood volume: correlative MR and PET observations. J Comput Assist Tomogr. 1990;14:905-908.
24. Yamauchi H, Fukuyama H, Kimura J. Hemodynamic and metabolic changes in crossed cerebellar hypoperfusion. Stroke. 1992;23:855-860.
25. Witte OW, Stoll G. Delayed and remote effects of focal cortical infarctions: secondary damage and reactive plasticity. Adv Neurol. 1997;73:207-227.
26. Powers WJ, Martin WRW, Herscovitch P, Raichle ME, Grubb RL. Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. Neurology. 1984;34:1168-1174.
27. Yamauchi H, Kudoh T, Sugimoto K, Takahashi M, Kishibe Y, Okazawa H. Pattern of collaterals, type of infarcts, and hemodynamic impairment in carotid artery occlusion. J Neurol Neurosurg Psychiatry. 2004;76:1697-1701.
28. Yamauchi H, Pagani M, Fukuyama H, et al. Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxygen metabolism after carotid artery occlusion: a follow up study with MRI and PET. J Neurol Neurosurg Psychiatry. 1995;59:420-426.
29. Yamauchi H, Pagani M, Fukuyama H, et al. Long-term changes of hemodynamics and metabolism after carotid artery occlusion. Neurology. 2000;54:2095-2102.
30. Yamauchi H, Fukuyama H, Nagahama Y, et al. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry. 1996;61:18-25.
31. Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in 5-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med. 1999;40:1992-1998.
32. Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
33. Moriwaki H, Matsumoto M, Hashikawa K, et al. Hemodynamic aspect of cerebral watershed infarction: assessment of perfusion reserve using iodine-123-iodoamphetamine SPECT. J Nucl Med. 1997;38:1556-1562.
34. Derdeyn CP, Khosla A, Videen TO, et al. Severe hemodynamic impairment and border zone-region infarction. Radiology. 2001;220:195-201.
35. Yamauchi H, Fukuyama H, Yamaguchi S, Miyoshi T, Kimura J, Konishi J. High intensity area in the deep white matter indicating hemodynamic compromise in internal carotid artery occlusive disorders. Arch Neurol. 1991;48:1067-1071.
36. Toyama H, Matsumura K, Nakashima H, et al. Characterization of neuronal damage by iomazenil binding and cerebral blood flow in an ischemic rat model. Ann Nucl Med. 1998;12:267-273.
37. Watanabe N, Young AR, Garcia JH, et al. Focal cerebral ischemia and chronic-stage reduced flumazenil uptake in anesthetized baboons: a PET study with combined histological analysis [abstract]. J Cereb Blood Flow Metab. 1999;19(suppl 1):S316.
38. 123I-iomazenil. J Nucl Med. 2003;44:1168-1175.
39. Auer RN. Histopathology of cerebral ischemia. In: Mohr JP, Choi DW, Grotta JG, Weir B, Wolf PA, eds. Stroke: Pathophysiology, Diagnosis and Management. 4th ed. Philadelphia, PA: Churchill Livingstone; 2004:821-828.
40. Ihara M, Tomimoto H, Ishizu K, et al. Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke. 2004;35:942-947.